- Vaccines contain weakened or killed parts of bacteria and viruses to stimulate the immune system and prevent infectious diseases from spreading. The goal is to induce immunity against potential future infections.
- Different types of vaccines include live attenuated, inactivated, subunit, toxoid, and conjugate vaccines. They work by exposing the body to antigens in a way that triggers protective antibodies and memory immune cells.
- Vaccines are administered via injection or mucosal surfaces to induce both systemic immunity and local immune responses where pathogens enter the body. This interrupts disease transmission and prevents infections.
5. SUMMARY
• Vaccines are necessary to prevent person-to-person transmission
of infectious diseases.
• Vaccines contain virulence factors from bacteria and
viruses.
• Vaccines stimulate systemic or mucosal immunity.
6. SUMMARY
• • Killed, attenuated, subunit, conjugate, and reassortment
• vaccines are licensed in the United States.
• • Adjuvants are added to vaccines to enhance the immune
• response to microbial and viral virulence factors.
• • Additives or excipients such as antibiotics, egg protein,
• monosodium glutamate, gelatin, and latex are found in
• vaccines.
8. INTRODUCTION
Vaccination began with Lady Mary Wortley
Montagu, the wife
of the English Ambassador to Turkey. In 1723,
she popularized
the Turkish practice of variolation, in which
small amounts of
dried smallpox were scratched into the skin
of healthy people.
9. VARUS,VACCA,
VACCINATION
In fact, the term variola comes from the Latin word varus,
meaning “mark on the skin.” Variolation proved to be
protective
against smallpox infection. In 1796, Edward Jenner heard
stories that dairymaids were immune to smallpox if they
had
previously been infected with cowpox. Jenner showed that
infections with cowpox provided protection from smallpox
and that cowpox could be transmitted from dairymaid to
dairymaid as a deliberate protection mechanism. Using the
Latin word vacca, meaning “cow,” Jenner coined the name
for
the new procedure vaccination
12. VIRULENCE FACTORS
include molecules that allow bacterial attachment
to mammalian cells such as bacterial pili and fimbriae;
polysaccharide capsules that surround pneumococcus and
Pseudomonas and prevent phagocytosis; and toxins produced
or released from gram-positive and gram-negative bacteria,
respectively
16. Three types of toxins are produced by
bacteria:
• (1) Exotoxins
• (2) Endotoxins
• (3) Enterotoxins
17. Three types of toxins are produced by
bacteria:
• (1) Exotoxins
• are proteins synthesized and secreted by gram-positive
• bacteria. Exotoxins destroy mammalian cells or disrupt cellular
• function. For example, diphtheria toxin inhibits ribosome
• function and protein translation in mammalian cells,
• which ultimately kills the cells. Tetanus toxin accelerates the
• production of neurotransmitters that promote muscle contraction
• in the face (lockjaw) or in the long muscles in the
• back (opistothenosis).
18. • (2) Endotoxins are lipopolysaccharide
• components of the gram-negative cell wall. They consist of
• a long antigenic polysaccharide and a lipid A fragment that
• interacts with mammalian cells and contributes to septic
• or endotoxic shock. Unlike exotoxins, endotoxins are only
• released on the death of the bacteria.
19. • (3) Enterotoxins are secreted molecules that cause food poisoning
and diarrhea.
Staphylococcal, cholera, and clostridia enterotoxins produce
transient effects in humans. Escherichia coli O157:H7 produces
a potent enterotoxin that causes severe diarrhea, dehydration,
and death.
20. Vaccines are administered
• by subcutaneous, intramuscular, or mucosal routes.
• Administration by the intramuscular or subcutaneous
route stimulates systemic immunity in the spleen,
lymph nodes, and peripheral blood.
21. prevent the spread
• The vaccines interrupt
person-to-person transmission and prevent the spread of
infectious agents to the critical organs in the body.
22. local immune
• Mucosal vaccines stimulate local immune responses to microbes at
the
point of entry into the body.
23. ROUTE OF ADMINISTRATION
AND MUCOSAL IMMUNITY
• The route of administration determines which mucosal surface
• is stimulated by microbial agents.
24. Oral administration
• induces antibody responses in the small intestine, ascending
• colon, and mammary and salivary glands.
29. Live Attenuated Vaccines
• Before a live organism can be used in a vaccine, it must
undergo a process known as attenuation, which reduces virulence
while maintaining immunogenicity.
,
31. the classic attenuation
• process, microbes are passed through unnatural hosts grown on
unusual media, or exposed to harsh chemicals for
extended periods. As a consequence, microbes usually lose
the critical genes necessary to produce virulence factors.
32. rationale attenuation inactivates
• Removes virulence genes by targeted mutation or gene deletion.
Because of their small genome, viruses are relatively
easy to attenuate.
39. Only three bacteria
• have been attenuated and used in vaccines.
• Live attenuated vaccines for typhoid fever and cholera are used in
some parts of the world.
• Attenuated Mycobacterium bovis, known as Bacille Calmette-Guérin
(BCG), is used as a vaccine in Europe and other countries.
40. In veterinary medicine
• a live attenuated Bacillus anthracis Sterne strain is used to vaccinate
cows and horses against anthrax.
41. Advantage vs disadvantages
• The use of live attenuated vaccines has advantages as well as
disadvantages.
• A major is that the body does not differentiate between an
attenuated microbe and a wildtype microbe, and both elicit a
vigorous, long-lasting immune response.
• Moreover, only one immunization is required for lasting protection.
42. Inactivated Vaccines
• Inactivated vaccines consist of organisms killed by physical or
chemical means. Killed bacteria are advantageous because they do
not revert to the virulent state and pose little health risk to
immunosuppressed subjects.
• However, they have several disadvantages. When administered
intramuscularly, subcutaneously, or by both routes, inactivated
vaccines are only weakly immunogenic and often require booster
immunizations to achieve lasting protection.
44. Subunit Vaccines
• Whole-cell vaccines often contain nonantigenic molecules that can
cause rare systemic and frequent local adverse health effects. Toxicity
is reduced by eliminating all nonantigenic molecules while retaining
the antigenic molecules or critical epitopes that are necessary for
protection against infection..
45. diphtheria–pertussis–tetanus
(DPT)
• the pertussis component of the diphtheria–pertussis–tetanus (DPT)
vaccine comprises inactivated pertussis toxin, purifiedfilamentous
hemagglutinin, fimbriae, and pertactin.
• Subunit vaccines are advantageous because they do not cause
infections and pose little risk to immunosuppressed individuals
46.
47.
48.
49.
50.
51.
52. . Diphtheria and tetanus
• Antibodies directed at the toxoid neutralize exotoxins before they
reach the target cell. Diphtheria and tetanus vaccines contain toxoids
which stimulate an immune response.
70. EXCIPIENTS IN VACCINES
• Excipients found in vaccines include
• antibiotics,
• Egg protein,
• monosodium glutamate,
• gelatin,
• yeast,
• and latex.